Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study is designed as a randomized controlled trial with patients assigned to
neuromuscular reversal with either sugammadex or neostigmine/glycopyrrolate reversal. The
study will not be blinded to the anesthesiologist to allow for appropriate decision-making on
timing and dosage of reversal. This is a single-center study.